Clinical Trial Update: Lentivirus Transduced Acute Myeloid Leukaemia Blasts Expressing B7.1 (CD80) and IL-2 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of lentivirus-transduced acute myeloid leukemia blasts engineered to express CD80 and IL-2. The study is sponsored by King's College Hosp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: King's College Hospital NHS Trust | Conditions: Leukemia, Myeloid, Acute | Phase 1 | Status: UNKNOWN